Literature DB >> 17566043

Disease progression and liver cancer in the ferroportin disease.

Elena Corradini, Francesca Ferrara, Teresa Pollicino, Alberto Vegetti, Gian Luca Abbati, Luisa Losi, Giovanni Raimondo, Antonello Pietrangelo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17566043      PMCID： PMC1994377          DOI： 10.1136/gut.2007.122549

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis.

Authors:  I H Manifold; D R Triger; J C Underwood
Journal:  Lancet       Date:  1983-08-20       Impact factor: 79.321

2.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

4.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

Authors:  Vinod Devalia; Kymberley Carter; Ann P Walker; Stephen J Perkins; Mark Worwood; Alison May; James S Dooley
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

5.  p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.

Authors:  A Puisieux; F Ponchel; M Ozturk
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

Review 6.  The ferroportin disease.

Authors:  Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

7.  The role of Kupffer cells in the surveillance of tumor growth in the liver.

Authors:  W Zhang; S Arii; T Sasaoki; Y Adachi; N Funaki; H Higashitsuji; S Fujita; M Furutani; M Mise; S Ishiguro
Journal:  J Surg Res       Date:  1993-08       Impact factor: 2.192

8.  Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene.

Authors:  A Pietrangelo; G Montosi; A Totaro; C Garuti; D Conte; S Cassanelli; M Fraquelli; C Sardini; F Vasta; P Gasparini
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

9.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.

Authors:  G Montosi; A Donovan; A Totaro; C Garuti; E Pignatti; S Cassanelli; C C Trenor; P Gasparini; N C Andrews; A Pietrangelo
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808
  9 in total
  8 in total

Review 1.  Iron sequestration and anemia of inflammation.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 2.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

3.  Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations.

Authors:  Domenico Girelli; Ivana De Domenico; Claudia Bozzini; Natascia Campostrini; Fabiana Busti; Annalisa Castagna; Nadia Soriani; Laura Cremonesi; Maurizio Ferrari; Romano Colombari; Diane McVey Ward; Jerry Kaplan; Roberto Corrocher
Journal:  J Hepatol       Date:  2008-07-17       Impact factor: 25.083

Review 4.  Occult HBV infection.

Authors:  Giovanni Raimondo; Gaia Caccamo; Roberto Filomia; Teresa Pollicino
Journal:  Semin Immunopathol       Date:  2012-07-26       Impact factor: 9.623

5.  Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Authors:  Roman Mayr; Andreas R Janecke; Melanie Schranz; William J H Griffiths; Wolfgang Vogel; Antonello Pietrangelo; Heinz Zoller
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

Review 6.  The clinical significance of occult HBV infection.

Authors:  Giovanni Squadrito; Rosaria Spinella; Giovanni Raimondo
Journal:  Ann Gastroenterol       Date:  2014

Review 7.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

Review 8.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.